Govt Shutdown to Have Limited Effect on Obamacare, Says CRS
“Substantial implementation” of the Affordable Care Act (ACA, also known as Obamacare) will continue even as most of the federal government is shutdown, the Congressional Research Service explained in a new report.
“A lapse in [government] funding does not automatically result in the suspension of applicable laws, including the filing and payment deadlines applicable to taxes created by the ACA…. Because a funding lapse is the result of legislative inaction, a government shutdown could not have the effect of either explicitly or implicitly repealing the underlying law,” the CRS report said.
See Affordable Care Act (ACA) and the Appropriations Process: FAQs Regarding Potential Legislative Changes and Effects of a Government Shutdown, September 27, 2013.
Other new and newly updated CRS reports obtained by Secrecy News include the following.
The President’s Emergency Plan for AIDS Relief (PEPFAR), U.S. Global HIV/AIDS, Tuberculosis, and Malaria Programs: A Description of Permanent and Expiring Authorities, September 27, 2013
In Brief: The September 2013 Terrorist Attack in Kenya, September 27, 2013
Farm-to-Food Price Dynamics, September 27, 2013
EPA Standards for Greenhouse Gas Emissions from Power Plants: Many Questions, Some Answers, September 30, 2013
Confirmation that the construction of the security perimeter and associated security infrastructure at RAF Lakenheath are still ongoing once again raises questions about whether U.S. nuclear weapons have already been deployed to the base.
Alaskans are sensibly pulling back from the vogue for bans and returning to a western tradition that has worked for more than half a century – one that welcomes innovation but also oversees it closely.
The strength of our nation’s data policy isn’t just in the rules we write, but in how effectively we translate those rules into a system that prioritizes the public good. Join us in this movement to design and build more resilient national data policies.
The human cost is measured in deaths. The financial cost is measured in the $52 billion taxpayers pay annually end stage renal disease – double NASA’s budget.